Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
Reg Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
September 27, 2021
CAMP4 Presents First Preclinical Data Demonstrating the Therapeutic Potential of its RNA Actuating Platform at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Read More
Contact Us
Privacy Policy
Menu
Newsroom
All
·
In the News
·
Press Releases
September 27, 2021
Press Releases
CAMP4 Presents First Preclinical Data Demonstrating the Therapeutic Potential of its RNA Actuating Platform at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
July 13, 2021
Press Releases
CAMP4 Therapeutics Expands Leadership and Board of Directors
July 6, 2021
In the News
Boston Business Journal
What’s in a name? Biotech companies look to stand out from the crowd
June 15, 2021
Press Releases
CAMP4 Raises $45 Million to Usher in a New Era of Programmable Therapeutics to Upregulate Genes
October 29, 2019
Press Releases
CAMP4 Therapeutics Expands Board of Directors with Appointment of Steven Holtzman as Chair and Dr. Paula Ragan as Director
October 25, 2019
Press Releases
Richard Young, Ph.D., Founder of CAMP4 Therapeutics, Elected to National Academy of Medicine
June 1, 2018
In the News
Polaris Partners
CAMP4’s trek to speed drug discovery and treat disease through prediction
June 1, 2018
In the News
GenomeWeb
Computational Biology Startup Camp4 Therapeutics Launches With $30M in Series A Funding
1
2
»
Media Contact:
Lindy Devereux
PR@camp4tx.com
Top
